DE60215521T2 - OBERFLÄCHENEXPRESSIONSVEKTOREN MIT pgsBCA, DEM FÜR POLY-GAMMA-GLUTAMAT-SYNTHETASE CODIERENDEN GEN, SOWIE VERFAHREN ZUR EXPRESSION EINES ZIELPROTEINS AN DER OBERFLÄCHE EINES DEN VEKTOR BENUTZENDEN MIKROORGANISMUS - Google Patents

OBERFLÄCHENEXPRESSIONSVEKTOREN MIT pgsBCA, DEM FÜR POLY-GAMMA-GLUTAMAT-SYNTHETASE CODIERENDEN GEN, SOWIE VERFAHREN ZUR EXPRESSION EINES ZIELPROTEINS AN DER OBERFLÄCHE EINES DEN VEKTOR BENUTZENDEN MIKROORGANISMUS Download PDF

Info

Publication number
DE60215521T2
DE60215521T2 DE60215521T DE60215521T DE60215521T2 DE 60215521 T2 DE60215521 T2 DE 60215521T2 DE 60215521 T DE60215521 T DE 60215521T DE 60215521 T DE60215521 T DE 60215521T DE 60215521 T2 DE60215521 T2 DE 60215521T2
Authority
DE
Germany
Prior art keywords
expression vector
gram
gene
protein
cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60215521T
Other languages
German (de)
English (en)
Other versions
DE60215521D1 (de
Inventor
Moon-Hee Yuseong-gu SUNG
Seung-Pyo Yuseong-gu HONG
Jong-Su 456-110 Anseong-si LEE
Chang-Min Jung
Chul-Joong Kim
Kenji Nankoku-shi SODA
Makoto Uji ASHIUCHI
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BioLeaders Corp
MD Lab Co Ltd
Original Assignee
BioLeaders Corp
MD Lab Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BioLeaders Corp, MD Lab Co Ltd filed Critical BioLeaders Corp
Publication of DE60215521D1 publication Critical patent/DE60215521D1/de
Application granted granted Critical
Publication of DE60215521T2 publication Critical patent/DE60215521T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C12N15/75—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Bacillus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1048—Glycosyltransferases (2.4)
    • C12N9/1051—Hexosyltransferases (2.4.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1288—Transferases for other substituted phosphate groups (2.7.8)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y204/00—Glycosyltransferases (2.4)
    • C12Y204/01—Hexosyltransferases (2.4.1)
    • C12Y204/01133—Xylosylprotein 4-beta-galactosyltransferase (2.4.1.133)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y207/00—Transferases transferring phosphorus-containing groups (2.7)
    • C12Y207/08—Transferases for other substituted phosphate groups (2.7.8)
    • C12Y207/08005—CDP-diacylglycerol-glycerol-3-phosphate 3-phosphatidyltransferase (2.7.8.5)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
DE60215521T 2001-08-10 2002-08-09 OBERFLÄCHENEXPRESSIONSVEKTOREN MIT pgsBCA, DEM FÜR POLY-GAMMA-GLUTAMAT-SYNTHETASE CODIERENDEN GEN, SOWIE VERFAHREN ZUR EXPRESSION EINES ZIELPROTEINS AN DER OBERFLÄCHE EINES DEN VEKTOR BENUTZENDEN MIKROORGANISMUS Expired - Lifetime DE60215521T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR20010048373 2001-08-10
KR2001048373 2001-08-10
PCT/KR2002/001522 WO2003014360A1 (en) 2001-08-10 2002-08-09 SURFACE EXPRESSION VECTORS HAVING pgsBCA, THE GENE CODING POLY-GAMMA-GLUTAMATE SYNTHETASE, AND A METHOD FOR EXPRESSION OF TARGET PROTEIN AT THE SURFACE OF MICROORGANISM USING THE VECTOR

Publications (2)

Publication Number Publication Date
DE60215521D1 DE60215521D1 (de) 2006-11-30
DE60215521T2 true DE60215521T2 (de) 2007-06-21

Family

ID=19713096

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60215521T Expired - Lifetime DE60215521T2 (de) 2001-08-10 2002-08-09 OBERFLÄCHENEXPRESSIONSVEKTOREN MIT pgsBCA, DEM FÜR POLY-GAMMA-GLUTAMAT-SYNTHETASE CODIERENDEN GEN, SOWIE VERFAHREN ZUR EXPRESSION EINES ZIELPROTEINS AN DER OBERFLÄCHE EINES DEN VEKTOR BENUTZENDEN MIKROORGANISMUS

Country Status (8)

Country Link
US (1) US7553636B2 (enExample)
EP (1) EP1421195B1 (enExample)
JP (1) JP4458844B2 (enExample)
KR (1) KR100469800B1 (enExample)
CN (1) CN1311082C (enExample)
AT (1) ATE342990T1 (enExample)
DE (1) DE60215521T2 (enExample)
WO (1) WO2003014360A1 (enExample)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100525759B1 (ko) * 2002-10-17 2005-11-03 한국생명공학연구원 바실러스 속 균주 유래의 폴리 감마 글루탐산합성유전자를 이용한 펩타이드 항생물질 Ｐ5와Ａｎａｌ3의 표면 발현 방법 및 그의 용도
CN100543140C (zh) 2002-10-17 2009-09-23 生物领先公司 抗hpv疫苗的载体以及该载体转化的微生物
RU2332457C2 (ru) * 2003-06-04 2008-08-27 Байолидерс Корпорейшн Вектор, обеспечивающий экспрессию антигена вируса sars на поверхности клеток, и микроорганизмы, трансформированные этим вектором
KR20050079162A (ko) * 2004-02-04 2005-08-09 주식회사 바이오리더스 파보바이러스 항원의 세포표면 발현벡터 및 상기 벡터에의해 형질전환된 미생물
US7255855B2 (en) * 2004-02-27 2007-08-14 Bioleaders Corporation Surface expression method of peptides P5 and Anal3 using the gene encoding poly-gamma-glutamate synthetase
JP2005312426A (ja) * 2004-03-31 2005-11-10 Bioleaders Japan:Kk タンパク質を表層提示する大腸菌
JPWO2006117927A1 (ja) * 2005-03-04 2008-12-18 サントリー株式会社 ポリグルタミン酸を産生する形質転換植物
JP2006262724A (ja) * 2005-03-22 2006-10-05 Kobe Univ タンパク質高発現乳酸菌
JPWO2006126682A1 (ja) * 2005-05-27 2008-12-25 財団法人化学及血清療法研究所 アルツハイマー病の予防・治療用ワクチン
KR100872042B1 (ko) * 2005-09-14 2008-12-05 주식회사 바이오리더스 마이오스타틴을 발현하는 세포표면 발현벡터 및 상기벡터에 의해 형질전환된 미생물
KR100578395B1 (ko) * 2005-11-11 2006-05-10 주식회사 바이오리더스 면역기능이 강화된 사균화 유산균 제제 및 그 제조방법
KR100782332B1 (ko) * 2006-01-23 2007-12-06 주식회사 바이오리더스 새우 흰 반점 바이러스 항원의 표면 발현벡터 및 이에 의해형질전환된 미생물
KR100985914B1 (ko) * 2006-12-13 2010-10-08 주식회사 바이오리더스 간암 특이 항원인 알파­페토단백질의 표면발현벡터 및 이에의해 형질전환된 미생물
KR100972843B1 (ko) 2007-03-22 2010-07-28 주식회사 바이오리더스 신규 항시적 고발현 프로모터 및 그 용도
KR100857861B1 (ko) * 2007-10-15 2008-09-11 주식회사 바이오리더스 Ｍｙｏ－２ 펩타이드 중합체와 마이오스타틴의 융합단백질표면발현용 벡터 및 상기 벡터로 형질전환된 미생물
KR101471043B1 (ko) 2009-01-08 2014-12-09 주식회사 바이오리더스 안정적인 항시적 고발현 자궁경부암 치료백신용 벡터 및 그에 의해 형질전환된 재조합 유산균
KR101564084B1 (ko) 2009-01-08 2015-10-29 주식회사 바이오리더스 ｒｅｐＥ 변이유전자를 함유하는 항시적 고발현 벡터
JP5669361B2 (ja) * 2009-03-17 2015-02-12 花王株式会社 ポリ−ガンマ−グルタミン酸の調整方法
JP5599153B2 (ja) * 2009-03-17 2014-10-01 花王株式会社 ポリ−ガンマ−グルタミン酸の製造方法
EP2479270B1 (en) 2009-09-17 2016-04-06 Morishita Jintan Co., Ltd. Gene expressing a bifidobacterium surface-presented fusion protein
JP5846523B2 (ja) * 2010-11-18 2016-01-20 国立大学法人神戸大学 βグルコシダーゼを発現する大腸菌
JP2014210747A (ja) 2013-04-19 2014-11-13 アンジェスＭｇ株式会社 細胞性免疫誘導能が改善された経口ワクチン
CN103555720B (zh) * 2013-11-19 2015-08-19 湖北工业大学 一种具有生产和回收纤维素内切酶双重功能的酵母菌株的构建
CN108350411B (zh) 2015-06-25 2021-06-22 白川利朗 口服肿瘤疫苗
EP3560513A4 (en) 2016-12-26 2020-10-14 National University Corporation Kobe University ANTICANCER THERAPY USING A COMBINATION OF AN ORAL TUMOR VACCINE AND AN IMMUNOSUPPRESSION INHIBITOR
KR20200000972A (ko) * 2018-06-26 2020-01-06 주식회사 바이오리더스 바실러스 속 균주 유래의 폴리감마글루탐산 합성유전자를 이용한 표면발현벡터 및 이를 이용한 단백질의 미생물표면 발현 방법
JP7170129B2 (ja) * 2018-10-10 2022-11-11 バイオリーダース コーポレイション ラクトバチルス・カゼイ由来の二種類のプロモーターを用いた二種の目的タンパク質の同時表面発現ベクター、およびこれを用いたタンパク質の微生物表面発現方法
CN113330119B (zh) * 2018-10-10 2024-07-12 生物领先公司 使用源自干酪乳杆菌的半乳糖变旋酶基因启动子用于组成型高表达的表面表达载体及其用途
CN111593029B (zh) * 2020-05-29 2022-05-17 江西省科学院微生物研究所 一种催化活性提高的γ-聚谷氨酸合成酶复合体及其编码基因
CN113512562B (zh) * 2021-04-28 2022-05-17 齐鲁工业大学 γ-聚谷氨酸在植物中异源合成提高植物抗逆性和产量的方法
CN114702559A (zh) * 2022-04-02 2022-07-05 江西师范大学 枯草芽孢杆菌蛋白PgsA及其在表面展示系统中的应用
KR20240053728A (ko) 2022-10-17 2024-04-25 주식회사 퓨처앤텍 세포외막 지질단백질 PrsA 발현계를 이용한 세포표면 대량발현 기술
CN118956803A (zh) * 2022-11-22 2024-11-15 中国农业科学院茶叶研究所 茶树甲基化儿茶素合成酶CsFAOMT2、编码基因及其应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5348867A (en) 1991-11-15 1994-09-20 George Georgiou Expression of proteins on bacterial surface
US5356797A (en) * 1991-11-15 1994-10-18 Board Of Regents, The University Of Texas Membrane expression of heterologous genes
WO1993024636A1 (en) 1992-05-29 1993-12-09 The University Of British Columbia Use of protein oprf for bacterial cell surface expression of oligopeptides
AU692140B2 (en) 1992-11-03 1998-06-04 Staffan Normark Fibronectin binding protein as well as its preparation
DE4243770A1 (de) * 1992-12-23 1994-06-30 Behringwerke Ag Verfahren zur Herstellung von rekombinanten und synthetischen Peptiden und deren Verwendung
EP0711303B2 (en) 1993-07-30 2009-06-10 Affymax, Inc. Biotinylation of proteins
FR2708622B1 (fr) 1993-08-02 1997-04-18 Raymond Hamers Vecteur recombinant contenant une séquence d'un gène de lipoprotéine de structure pour l'expression de séquences de nucléotides.
KR0185335B1 (ko) * 1996-04-02 1999-04-01 김은영 표면 발현 벡터 및 이를 이용한 단백질의 미생물 표면 발현 방법
JP2001017182A (ja) 1999-07-09 2001-01-23 Nagase & Co Ltd ポリ−γ−グルタミン酸の製造方法

Also Published As

Publication number Publication date
CN1311082C (zh) 2007-04-18
EP1421195A1 (en) 2004-05-26
JP2005500054A (ja) 2005-01-06
KR100469800B1 (ko) 2005-02-02
EP1421195B1 (en) 2006-10-18
DE60215521D1 (de) 2006-11-30
JP4458844B2 (ja) 2010-04-28
ATE342990T1 (de) 2006-11-15
CN1539018A (zh) 2004-10-20
WO2003014360A1 (en) 2003-02-20
US20040253704A1 (en) 2004-12-16
KR20040032824A (ko) 2004-04-17
EP1421195A4 (en) 2005-04-27
US7553636B2 (en) 2009-06-30

Similar Documents

Publication Publication Date Title
DE60215521T2 (de) OBERFLÄCHENEXPRESSIONSVEKTOREN MIT pgsBCA, DEM FÜR POLY-GAMMA-GLUTAMAT-SYNTHETASE CODIERENDEN GEN, SOWIE VERFAHREN ZUR EXPRESSION EINES ZIELPROTEINS AN DER OBERFLÄCHE EINES DEN VEKTOR BENUTZENDEN MIKROORGANISMUS
EP0584167B1 (en) Recombinant dna coding for signal peptide, selective interacting polypeptide and membrane anchoring sequence
JP3267333B2 (ja) 融合タンパク質
US20100172938A1 (en) Modified bacterial surface layer proteins
JPH11513562A (ja) 組換えプラスミドの生産方法
KR19990044528A (ko) 세포 표면에 세포성분의 부착 및 표현과 관련된 물질 및 방법
US8080402B2 (en) Surface expression method of peptides P5 and Anal3 using the gene encoding poly-gamma-glutamate synthetase
US6274345B1 (en) Expression vectors encoding Escherichia coli OmpC as a cell surface anchoring motif
US8158387B2 (en) Method for cell surface display of target proteins using FadL of E. coli
WO1987005025A1 (en) Cloned streptococcal genes encoding protein g and their use to construct recombinant microorganisms to produce protein g
JPH03501801A (ja) クローン化プロテインｇ変異体遺伝子及びそれから発現されたプロテインｇ変異体
JP2000503850A (ja) Ｓ―層―タンパク質の組み換え発現
US6610517B1 (en) Compartmentalization of recombinant polypeptides in host cells
AU747328B2 (en) Secretion of carrier-bonded proteins into the periplasma and the extracellular space
KR100525759B1 (ko) 바실러스 속 균주 유래의 폴리 감마 글루탐산합성유전자를 이용한 펩타이드 항생물질 Ｐ5와Ａｎａｌ3의 표면 발현 방법 및 그의 용도
WO1999051631A1 (en) A protein region responsible of binding to epithelial cell types and a dna sequence encoding said region
JP2025536332A (ja) 細胞外膜リポタンパク質ＰｒｓＡ発現系を用いた細胞表面大量発現技術

Legal Events

Date Code Title Description
8364 No opposition during term of opposition